Neurocrine Biosciences Overview

Neurocrine Biosciences Operating Income

Operating Income for NBIX.

Quarterly Operating Income

$186.00M

↑ 688.14% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$781.50M

↑ 57.94% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin